Xiaflex (collagenase clostridium histolyticum) Approved by FDA To Treat Peyronie’s Disease

First gun, Xiaflex (collagenase clostridium histolyticum) to treat patients suffering from Peyronie’s disease has been approved by U.S. Food and Drug Administration (FDA). Patients may experience curative deformity during erection that results due to penis lump formation.

Continue reading Xiaflex (collagenase clostridium histolyticum) Approved by FDA To Treat Peyronie’s Disease